286 results match your criteria: "Centre pédiatrique d'Allergologie[Affiliation]"

Methotrexate for atopic dermatitis: The right dosing and best-performance administration route.

J Eur Acad Dermatol Venereol

February 2025

CIRI (International Center for Infectiology Research) INSERM U1111, Ecole Normale Supérieure de Lyon, Université Claude Bernard Lyon 1 CNRS UMR5308, Lyon, France.

View Article and Find Full Text PDF

Daycare use of disinfectants and cleaning products and wheeze among children: Cross-sectional analyses in the French CRESPI cohort.

Sci Total Environ

January 2025

Université Paris-Saclay, UVSQ, Univ. Paris-Sud, Inserm, Équipe d'Épidémiologie Respiratoire Intégrative, CESP, 94807 Villejuif, France. Electronic address:

Background: Evidence is mounting that domestic use of disinfectants and cleaning products (DCP), particularly in spray form, is associated with wheezing in children. Beyond the home environment, many children are also exposed to DCP in daycare. The links between daycare exposures to DCP and child respiratory health have never before been studied.

View Article and Find Full Text PDF

Background: Several major sensitization profiles have been described in children with asthma, but it remains unclear how these profiles relate to asthma phenotypes. The aim of this study was to determine allergenic sensitization profiles in a megacity cohort (SAMP).

Methods: This was a cross-sectional analysis performed from 2011 to 2015 including preschool and school-age children with severe and moderate asthma from the SAMP cohort.

View Article and Find Full Text PDF

Diagnostic and prognostic performance of positron emission tomography/computed tomography in eosinophilic fasciitis: An observational multicenter retrospective study.

J Am Acad Dermatol

November 2024

Service de Médecine Interne, Centre de Référence Maladies Systémiques Autoimmunes et Autoinflammatoires Rares d'Ile de France de l'Est et de l'Ouest, Hôpital Cochin, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France; APHP-CUP, Hôpital Cochin, Université Paris Cité, Paris, France. Electronic address:

View Article and Find Full Text PDF
Article Synopsis
  • A study investigated how the antioxidant capacity and inflammation potential of maternal diets during the last three months of pregnancy could influence the risk of allergic and respiratory diseases in children.
  • Researchers analyzed data from 9,679 mother-child pairs, measuring the dietary antioxidant capacity and inflammatory potential using various indices.
  • Results indicated that a diet high in antioxidants was linked to a lower risk of 'early wheeze without asthma,' while a pro-inflammatory diet correlated with a higher risk of 'asthma only,' suggesting maternal diet impacts children's respiratory health to some extent.
View Article and Find Full Text PDF

High burden of respiratory allergy in children warrants early identification and treatment with allergen immunotherapy.

Respir Med

November 2024

Department of Pediatrics and Department of Clinical Immunology and Allergology, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, University Hospital in Martin, Martin, Slovakia. Electronic address:

Article Synopsis
  • Respiratory allergies often start in childhood and mainly show up as allergic rhinitis and/or asthma, which can significantly affect a child's quality of life.
  • These allergies frequently coexist with other issues like asthma and gastrointestinal or mental health problems, highlighting the importance of early diagnosis.
  • Allergen immunotherapy (AIT) is suggested as a potential early treatment option to help alter the course of respiratory allergies and improve long-term outcomes for affected children.
View Article and Find Full Text PDF
Article Synopsis
  • Advanced systemic mastocytosis (AdvSM) is a complex condition linked to poor outcomes, and while midostaurin is the first approved treatment, its long-lasting effectiveness is limited.
  • Various prognostic scoring systems like MARS, IPSM, and GPSM have been developed to assess patients' outcomes, but it's essential to tailor these scores to specific AdvSM subtypes for better accuracy.
  • A study of patients treated with midostaurin revealed that MARS and AdvSM subtype significantly predict overall survival, identifying five distinct patient subgroups with varying median survival times, highlighting the need for personalized management strategies.
View Article and Find Full Text PDF

[Definition, positive and differential diagnosis].

Rev Mal Respir

September 2024

Service de pneumologie et d'allergologie pédiatrique, CHU de Lenval, université Côte d'Azur, hôpitaux pédiatriques de Nice, Nice, France.

View Article and Find Full Text PDF

In patients with moderate to severe atopic dermatitis (AD) showing an inadequate response to dupilumab 300mg/2weeks, few real-life studies reported the response to alternative regimen maintaining dupilumab. To assess and analyze the response to an increased dose of dupilumab or its combination with cyclosporin A (CsA), methotrexate (MTX), or itraconazole (ITRA), all adult AD patients from 7 French University Hospitals were retrospectively included if they achieved an inadequate response to dupilumab 300mg/2weeks and were subsequently treated with an increased dose of dupilumab (300mg every 7 or 10 days), or a combination of dupilumab 300mg/2weeks with CsA, MTX or ITRA. The response after 3 months, along with epidemiological, clinical, and therapeutic baseline characteristics, were collected.

View Article and Find Full Text PDF

Climate change and children's respiratory health.

Paediatr Respir Rev

July 2024

Université Paris Cité, Paris, France; Service de pneumologie et d'allergologie pédiatrique, hôpital universitaire Necker-Enfants-Malades, AP-HP, 149, rue de Sèvres, 75015 Paris, France; Inserm UMR 1138, équipe HeKA, Centre de Recherche des Cordeliers, France. Electronic address:

Climate change has significant consequences for children's respiratory health. Rising temperatures and extreme weather events increase children's exposure to allergens, mould, and air pollutants. Children are particularly vulnerable to these airborne particles due to their higher ventilation per unit of body weight, more frequent mouth breathing, and outdoor activities.

View Article and Find Full Text PDF

A quick access to information on influenza burden and prevention in Lyon university hospital: A prospective QR code-based information campaign in 2022-2023.

Vaccine

August 2024

Unité d'hygiène, épidémiologie et prévention, Hôpital Edouard Herriot (HEH), Hospices Civils de Lyon (HCL), Lyon, France; Centre International de Recherche en Infectiologie (CIRI), Inserm U1111, CNRS UMR5308, ENS de Lyon, Université de Lyon 1, Lyon, France; Inserm, F-CRIN, Réseau Innovative Clinical Research in Vaccinology (I-REIVAC), Paris, France.

Background: Influenza vaccines are effective in decreasing hospitalizations and mortality related to influenza and its complications. However, the Vaccine Coverage Rate of influenza remains low and multifaceted efforts are required to improve it. The aim of this study was to assess the impact on influenza vaccine perception using a digital tool among outpatients and health care workers (HCWs).

View Article and Find Full Text PDF
Article Synopsis
  • * Out of 153 patients, 20% needed a dose increase after 3 months, and this rose to 27% by 9 months, primarily by increasing injection frequency rather than dosage.
  • * Patients requiring updosing were typically those with more severe CSU symptoms and lower IgE levels, but side effects did not increase as a result of higher dosing.
View Article and Find Full Text PDF

Unusual dermatitis in response to a transcutaneous electrical nerve stimulation device.

Eur J Dermatol

June 2024

Hospices Civils de Lyon, Centre Hospitalier Lyon Sud, Service d'Allergologie et Immunologie Clinique, Pierre Bénite cedex, F-96495, France, CIRI - Centre International de Recherche en Infectiologie (Team Epidermal Immunity and Allergy), Inserm U1111, CNRS UMR 5308, ENS de Lyon, Lyon.

View Article and Find Full Text PDF

Concepts for the Development of Person-Centered, Digitally Enabled, Artificial Intelligence-Assisted ARIA Care Pathways (ARIA 2024).

J Allergy Clin Immunol Pract

October 2024

University Clinic of Respiratory and Allergic Diseases, Pulmonary & Allergy Department, Golnik, Slovenia; Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia.

Article Synopsis
  • - The traditional healthcare approach often overlooks patients' personal experiences and strengths, focusing mainly on disease treatment. Person-centered care aims to align medical decisions with individual values and preferences, particularly for those with chronic conditions.
  • - This paper seeks to enhance care for rhinitis and asthma by developing digital care pathways and incorporating real-world evidence to create a more patient-centered approach.
  • - Key components of the review include advancements in mHealth, the integration of artificial intelligence, a novel classification system for airway diseases, and proposals for the ARIA 2024 guidelines, all targeting a sustainable and applicable healthcare model.
View Article and Find Full Text PDF
Article Synopsis
  • Atopic dermatitis (AD) is a long-lasting skin condition that can significantly affect a person's quality of life and mental health.
  • A study evaluated the effectiveness of lebrikizumab on quality of life and mental health in patients with moderate-to-severe AD over a 16-week period, using various assessment tools.
  • Results showed notable improvements in overall quality of life, anxiety, and depression among those treated with lebrikizumab compared to placebo, indicating its potential benefits for patients suffering from AD.
View Article and Find Full Text PDF

Maternal diet quality with child allergic and respiratory multimorbidity in the Elfe birth cohort.

Sci Rep

June 2024

Université Paris-Saclay, UVSQ, Univ. Paris-Sud, Inserm, Équipe d'Épidémiologie respiratoire intégrative, CESP, Villejuif, France.

Article Synopsis
  • The study investigates the relationship between maternal diet during pregnancy and the development of allergic and respiratory diseases in children, focusing on data from 9679 mother-child pairs.
  • Maternal diet quality was assessed through various scores, revealing that higher nutrient intake, particularly from legumes, may reduce the risk of children experiencing "early wheeze without asthma."
  • The findings suggest that while adequate nutrient intake during pregnancy is weakly linked to lower respiratory issues in children, the specific impacts of legume and fish consumption show potential benefits for allergic disease prevention.
View Article and Find Full Text PDF

Staphylococcus aureus-specific skin resident memory T cells protect against bacteria colonization but exacerbate atopic dermatitis-like flares in mice.

J Allergy Clin Immunol

August 2024

Centre International de Recherche en Infectiologie (CIRI), INSERM U1111, Unité Mixte de Recherche 5308, Centre national de la recherche scientifique, Ecole Normale Supérieure de Lyon, Lyon, France. Electronic address:

Background: The contribution of Staphylococcus aureus to the exacerbation of atopic dermatitis (AD) is widely documented, but its role as a primary trigger of AD skin symptoms remains poorly explored.

Objectives: This study sought to reappraise the main bacterial factors and underlying immune mechanisms by which S aureus triggers AD-like inflammation.

Methods: This study capitalized on a preclinical model, in which different clinical isolates were applied in the absence of any prior experimental skin injury.

View Article and Find Full Text PDF

[Antihistamines : An ongoing narrative].

Rev Med Suisse

April 2024

Unité de pharmacogénétique et de psychopharmacologie clinique, Centre de neurosciences psychiatriques, Département de psychiatrie, Centre hospitalier universitaire vaudois et Université de Lausanne, 1011 Lausanne.

Histamine is responsible for many processes mediated by different receptors expressed on a variety of cells. The discovery of the first H1 antihistamines in the 1940s led to the development of numerous H1 and H2 antagonists with a broad application in many indications. The recent identification of two new histamine receptors (H3, H4) in the 1980s and 2000s led to the market authorization in Switzerland of new drugs since 2018.

View Article and Find Full Text PDF

[CAR-T therapy for autoimmune diseases].

Rev Med Suisse

April 2024

Service d'immunologie et allergie, Département de médecine, Centre hospitalier universitaire vaudois, 1011 Lausanne.

Cellular therapy using genetically modified T lymphocytes expressing synthetic receptors, known as CAR (Chimeric Antigen Receptor), has revolutionized the treatment of certain hematologic malignancies. This success has led to exploring the same approach in the treatment of severe autoimmune diseases refractory to conventional therapies. Initial results in systemic lupus erythematosus have shown complete remissions that appear to persist over time.

View Article and Find Full Text PDF

[Cardiac sarcoidosis: a diagnostic and therapeutic challenge].

Rev Med Suisse

April 2024

Service d'allergologie et d'immunologie clinique, Département de médecine, Hôpitaux universitaires de Genève, 1211 Genève 14.

The diagnosis of cardiac sarcoidosis, particularly in its isolated cardiac form, represents a major challenge due to non-specific symptoms and the limited sensitivity and specificity of basic cardiac investigations. MRI and metabolic PET-CT are important elements in the diagnostic process. Corticosteroids remain the cornerstone for the treatment of the inflammatory phase, in association with biological agents and steroid-sparing therapies.

View Article and Find Full Text PDF

Background And Aims: Systemic mastocytosis (SM) is characterized by the accumulation of atypical mast cells (MCs) in organs. Liver histology of SM has been marginally described and accurate histological classification is critical, given the consequences of aggressive SM diagnosis. We aimed to describe the histological features associated with liver SM using updated tools.

View Article and Find Full Text PDF

PCSK9 inhibition protects mice from food allergy.

Transl Res

October 2024

Nantes Université, CHU Nantes, CNRS, INSERM, l'institut du thorax, 8 quai Moncousu, BP70721, Nantes 44000, France. Electronic address:

Article Synopsis
  • * Research indicates that mice lacking PCSK9 or treated with specific antibodies against PCSK9 show protection from gliadin-induced food allergies, evident by reduced intestinal symptoms and inflammation.
  • * Notably, the protective effects of PCSK9 inhibition occur independently of the LDLR, as it remains effective even in LDLR-deficient mice, highlighting PCSK9's role in allergic responses.
View Article and Find Full Text PDF
Article Synopsis
  • Cutaneous lupus erythematosus (CLE) can occur on its own or alongside systemic lupus erythematosus (SLE), where lab tests show specific abnormalities.
  • This study aimed to compare isolated CLE to CLE with lab-confirmed SLE and to validate a scoring system predicting the risk of developing severe SLE (sSLE).
  • Results indicated that patients with CLE and laboratory SLE had a significantly higher risk of progressing to sSLE compared to those with isolated CLE, though the study had limitations due to its small, single-center patient sample.
View Article and Find Full Text PDF